ArticleiScience2025

Niclosamide nanoparticles enhance pancreatic cancer sensitivity to gemcitabine via HIF-1α inhibition.

Susheel Kumar Nethi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.